Skip to content
Catalyst

PapersPMID:32503652

The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes.

Trials2020The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidencelowersLDL cholesterol
  2. Finding, moderate evidenceraisesHDL cholesterol
Study, every finding
RCT · 8 weeks
Dose studied, every finding
1 g capsules, three capsules three times per day after each meal, 8 weeks (Methods)
Population, every finding
Adults aged 30-60 with type 2 diabetes, BMI 25-35 and gastrointestinal symptoms; 42 completers, 21 per arm; dill powder against starch placebo for 8 weeks
  • “Furthermore, the serum levels of LDL-C decreased to a greater extent in the intervention group between the start and the end of the study than in the control group (−9.76 ± 19.08 vs 3.09 ± 14.07 mg/dl, respectively; P = 0.017).”
    Interests
    Industry funded
  • “Furthermore, the mean changes in serum levels of HDL were significantly higher in the intervention group compared to the control group (2.59 ± 4.51 vs −1.38 ± 4.60 mg/dl, respectively; P = 0.004).”
    Interests
    Industry funded

Study record

Design
randomised controlled trial
Species
human
Population
Patients with type 2 diabetes mellitus and gastrointestinal symptoms, Golestan Hospital, Ahvaz, Iran; dried dill (Anethum graveolens) leaves milled to powder in capsules. The Methods text says 100 patients, 48 randomised and 42 completed; the Methods describe three capsules of 1 g three times per day, while the abstract (not quoted) says 3 g/day
Participants
42
Comparator
placebo
Duration
56 days
Endpoints measured
80